Is AbbVie Stock a Top Pick for 2022?

·4 min read
Is AbbVie Stock a Top Pick for 2022?

Treasury yields are rising, and the Federal Reserve is expected to raise interest rates multiple times in 2022. In the case of AbbVie (NYSE: ABBV), look no further. AbbVie is a global prescription drug developer, manufacturer, and distributor that was spun off from parent company Abbott Labs back in 2013.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting